Background: Diabetic peripheral neuropathy (DPN) is a common complication among children with TIDM and is related to poor glycemic control. The aim of the study is to determine prevalence and determinants of diabetic neuropathy in diabetic children. Material& Methods: This is a cross sectional study conducted on 50 children having Type I diabetes mellitus for more than year presented to Pediatric Neurology and Endocrinology Outpatient Clinics, Sohag University Hospital, Sohag, Egypt, during one year duration (2017). Children were subjected to detailed neurological examination and electrophysiologic studies in addition to recording of socio demographic and laboratory findings with special regard to level of HbA1c. Results: The mean age of the studied children was 10.5 ± 0.3 years ranging from 5 to 18 years. 22 cases (44%) were younger than 10 years, 27 children (54%) were females. DPN was diagnosed in 12% of the studied children. No significant relation was found as regard age, gender, family history, consanguinity and duration of the diseases. Significant association was found between the HbA1c level and development of DPN in the studied children. Conclusion: Based on the results of this study, 12% of the studied diabetic children had DPN of whom more than 16% had subclinical neuropathy indicating the need for annual screening of neuropathy using Nerve Conduction Study. Moreover strict glycaemic control is needed to prevent rapid development of diabetic among these children.
considered one of the most common endocrine diseases in childhood and constitutes 5% -10% of patients with diabetes [1] . The annual incidence of T1DM varied from 0.61 cases per 100,000 populations in China to 57.6 cases per 100,000 in Finland [2] . Middle East region, Saudi Arabia and Kuwait have the highest incidence rate at 31.4 and 22.3/100,000 per year [3] . In Egypt, the prevalence of type I diabetes in adolescents was 0.6% and there is growing epidemic of diabetes among children and adolescents [4] .
Diabetic neuropathy is known as a set of varied clinical syndromes with sensory, motor, and/or autonomic nerve fiber dysfunction, although the most common type is symmetrical distal sensory polyneuropathy (DPN) [5] . Diabetic peripheral neuropathy (DPN) is a common complication of T1DM, and unlike adults, patient's polyneuropathy has no clinical manifestations in diabetic children in its early stages [6] . Clinical examination had less sensitivity and specificity than nerve conduction studies, which serves as a gold standard to detect subclinical neuropathy in these patients [7] . DPN is a major cause of morbidity and poor quality of life in patients with diabetes mellitus. It can increase the chances of other complications, namely amputation and foot ulcer [8] .
Abnormalities of nerve conduction are common findings in children with diabetes. The prevalence of DPN in both adults and children ranges between 7% and 57% (8 m), and the highest prevalence for DPN is found in children and adolescents with poor glycemic control and longer duration of diabetes, abnormal lipid profile, which are considered important risk factors for DPN [9] [10].
Patients with TIDM have subclinical neuropathy long before occurrence of evident neuropathy, Moreover once symptoms appear, there are few effective therapeutic strategies [11] [12] . This indicates importance of early identification of DPN, in its primary stages to prepare appropriate measures to prevent its development. However, few studies have evaluated the subclinical neuropathy in these patients, and also the prevalence of early stages of DPN among children and adolescents is not well-known.
The aim of this research was to evaluate the prevalence of DPN (both clinical and subclinical subtypes) and its possible risk-factors in children with insulin dependent DM.
Material & Method

Study Design
This is a cross sectional study conducted to determine prevalence and determinants of DPN in diabetic children presented to Pediatric department in one year duration extending from October 1 st 2016 to September 30 th 2017.
Study Population
All patients from 5 to 18 years suffering from diabetes mellitus type 1 for more than one year presented to Neurology and Endocrine Outpatient Clinics during the period of the study were included in this study. Exclusion criteria included:
diabetic patients with duration of diabetes less than 1 year, age younger than 5 years old or older than 18 years old, children with other chronic diseases, handicapped children, children with cancer, chronic renal impairment, or other neurological diseases and children who were on medications that can produce peripheral neuropathy, i.e. antineoplastic drugs. Accordingly 50 patients were included in the study. 
Data Collection Procedure
Ethical Consideration
Results
The mean age of the studied children was 10.5 ± 0.3 years ranging from 5 to 18
years. Among the studied 50 children having TIDM 22 cases (44%) were younger than 10 years, 27 children (54%) were females and 25 children (50%) were from urban areas. Family history of diabetes was found in 27 cases (54%), while positive consanguinity was detected in 20 cases (40%).
Among the studied children with type I diabetes 12% were diagnosed as having diabetic neuropathy as displayed in Figure 1 . As regard the type of neuropathy, one case (2%) subclinical neuropathy, two cases (4%) had mild sensory axonal neuropathy, 2 cases (4%) had mild sensory motor axonal neuropathy, and one case (2%) had moderate sensory motor axonal neuropathy (Figure 2 ). 
Discussion
DPN is a chronic complication of the diabetes that is rarely reported in children, since it has a relatively longer latency period [13] [14] . Our main objective in this study was to determine the prevalence of DPN among diabetic children and to assess the percent of subclinical neuropathy in addition to identification of possible risk factors of DPN among these children.
Our findings showed that 12% of the studied diabetic children had DPN.
These findings are in agreement with [15] and [16] who reported a prevalence rate of 11% and 13.75%. However Effat et al., reported much higher prevalence (23%) among the studied children having TIDM [17] . Moreover Hollner et al.
reported that the incidence of DN was 15% in symptomatic DN cases and 38% in DN cases diagnosed by NCS [18] . Their conclusion was that in type 1DM that is seen in children and adolescents, DPN had a higher prevalence rate; however, the majority of cases remain subclinical. But in our study the majority of diag- to 60% of all patients with diabetes are affected by DPN [21] . However, the estimated rates of children are inaccurate, considering the prevalence of subclinical diabetic neuropathy observation in this age group.
Based on results of NCV and compared with clinical examination of the studied diabetic children, we found that 2% of diabetic children had subclinical neuropathy, they showed no symptoms or signs of neuropathy on clinical examination. On the other hands these cases of subclinical neuropathy constituted 16% of the total diagnosed cases of DPN. In agreement with our findings but with much more percentages of subclinical neuropathy were the findings of Toopchizadeh et al., who reported that among the diagnosed cases of DPN (57.5%) showed no symptoms of neuropathy [20] . Moreover, Nelson et al. [5] found subclinical neuropathy based on nerve conduction findings in 57% of
Canadian children and adolescents with at least 5 years duration of T1DM. Baba and Ozaki found polyneuropathy using neurologic examinations in 43% of the studied diabetic children and using electro diagnostic studies in 63% of children and adolescents without clinical neuropathy [22] . These results indicate that, routine nerve conduction velocity (NCV) assessment for DN is beneficial in those patient groups [18] .
The lack of standardization of screening methods seems to be a general problem in diagnostic research on DPN There is considerable uncertainty about the prevalence of diabetic neuropathy (DN) due to a lack of large epidemiological studies and consensus on diagnostic criteria.
As regard factors associated with occurrence of DPN among the studied diabetic children, in agreement with [20] , no significant relation was found for age gender, residence, consanguinity and family history.
Association between DPN and duration of diabetes had been assessed and reported by many previous studies especially in adolescents and adults, however in children this association remains a matter of controversy. On contrary to [5] [23], we found no significant association between duration of diabetes and development of DPN. Although these findings agree with [20] [24] [25] .
The level of glycaemic control in the studied diabetic children was unsatisfactory (a mean of 8.9 among the normal group and 16.2 among the group having DN). As recommended by the International Society for Pediatric and Adolescent Diabetes (ISPAD) a level of <7.5% (HbA1c) is crucial for a good metabolic control for all age-groups. As long-term good metabolic control reduces the total risk of complications in type 1 DM [26] . In agreement with our finding several previous researches [23] [25] [27] demonstrated that poor glycaemic control contribute significantly in development of DN among diabetic children.
Conclusion
Based on the results of the current study, subclinical peripheral neuropathy is frequent complication in diabetic children that related to poor glycaemic control 
Limitation of the Study
The major limitation of the study was the reduced no of children with TI DM.
This can be explained by the fact that NCA is a painful investigation that needs cooperation of the child. And many children refused to complete the test. 
